Masimo Reports Second Quarter 2024 Financial Results

About this update from Masimo Corporation

[{"type":"text","content":"\nSecond Quarter 2024 Highlights:\n\n\n\nConsolidated revenue was $496.3 million;\n\n\n\nHealthcare revenue was $343.9 million;\n\n\n\nNon-healthcare revenue was $152.4 million;\n\n\n\nGAAP net income per diluted share was $0.29; and\n\n\n\nNon-GAAP net income per diluted share was $0.86.\n\n\n\n IRVINE, Calif.--(BUSINESS WIRE)--\nMasimo Corporation (Nasdaq: MASI) today announced its financial results for the second quarter ended June 29, 2024.\n\n\nSecond Quarter 2024 Results:\n\n\nConsolidated revenue was $496.3 million, comprised of healthcare revenue of $343.9 million and non-healthcare revenue of $152.4 million.\n\n\nExcluding handheld and fingertip pulse oximeters, shipments of noninvasive technology boards and instruments were 58,600.\n\n\nConsolidated GAAP operating income was $28.3 million. Consolidated non-GAAP operating income was $72.9 million. Consolidated GAAP net income was $16.0 million, or $0.29 per diluted share. Consolidated non-GAAP net income was $46.6 million, or $0.86 per diluted share.\n\n\nJoe Kiani, Chairman and Chief Executive Officer of Masimo, said, “Our team’s record-breaking contracting efforts, exceptional execution of margin expansion initiatives and continued innovation drove strong results for shareholders in the second quarter. On the back of that performance and our growing momentum in the healthcare market, we are increasing our full-year 2024 guidance for healthcare revenue, consolidated operating income and consolidated EPS.”\n\n\nFor additional financial details, please visit the Investor Relations section of the Company’s website at investor.masimo.com to access the second quarter 2024 earnings presentation materials.\n\n\nThird Quarter 2024 and Updated Full-Year 2024 Financial Guidance:\n\n\nThe Company provided the following estimates for its third quarter 2024 and updated full-year 2024 guidance:\n\n\n\n\n \n\n\n\n\n\n\n \n\n\n\n\n\n\nQ3 2024\n\n\n\n\nGuidance(1)\n\n\n\n\n\n\n \n\n\n\n\n\n\nUpdated Full-Year\n\n\n\n\n2024 Guidance(1)\n\n\n\n\n\n\n\n\n(in millions, except earnings per diluted share)\n\n\n\n\n\n\n \n\n\n\n\n\n\nGAAP\n\n\n\n\n\n\n \n\n\n\n\n\n\nNon-GAAP\n\n\n\n\n(Updated Definition)(2)\n\n\n\n\n\n\n \n\n\n\n\n\n\nGAAP\n\n\n\n\n\n\n \n\n\n\n\n\n\nNon-GAAP\n\n\n\n\n(Updated Definition)(2)\n\n\n\n\n\n\n\n\nConsolidated revenue\n\n\n\n\n\n\n \n\n\n\n\n\n\n$495 to $515\n\n\n\...

More updates from Masimo Corporation